Results of a Trial Comparing Cabozantinib and Sunitinib in mRCC

October 26, 2016
Toni Choueiri, MD

Toni Choueiri, MD, discusses the results of the ALLIANCE A031203 trial comparing cabozantinib and sunitinib in metastatic renal cell carcinoma (mRCC).